It has been shown previously that the muscarinic cholinergic system in the nucleus raphe magnus (NRM) is involved in the modulation of nociception.
In this study, we examined the direct actions of muscarine on the NRM neurons in a slice preparation.
Muscarine (I-30 PM) produced a dosedependent hyperpolarization in a subpopulation of the NRM cells that contain 5-hydroxytryptamine (5-HT). In voltage clamp, the muscarine-induced outward current reversed polarity at the potassium equilibrium potential and was characterized by strong inward rectification. The reversal potential was dependent on external potassium concentration, suggesting that the hyperpolarization induced by muscarine was mediated through an increase in an inwardly rectifying potassium conductance.
5-HT also hyperpolarized these cells by increasing the same inwardly rectifying potassium conductance. The concentration-response curve for muscarine (EC,, = 2.7 @I) was shifted in a parallel manner to the right by increasing concentrations of pirenzepine (300 nM to 3 FM) and methoctramine (50-200 nM) . Schild analysis revealed that the equilibrium dissociation constant (KJ was 230 nM for pirenzepine and was estimated to be less than 30 nM for methoctramine.
These results indicate that the muscarinic receptor mediating the muscarine activation of the potassium conductance in these cells is of the M, subtype. The present results suggest an inhibitory cholinergic postsynaptic modulation on the activity of a subpopulation of serotonergic neurons that are involved in antinociceptive function in the NRM.
[Key words: muscarine, M, moscarinic receptor, inwardly rectifying potassium conductance, pirenzepine, methoctramine, nucleus raphe magnus] Neurons in the nucleus raphe magnus (NRM) are involved in the descending modulation of nociceptive processing from supraspinal levels (Basbaum and Fields, 1984) . Functionally, there are different groups of putative pain-modulating neurons in the NRM and modulation ofthe activity in these neurons by opioids and other neurotransmitters results in a significant change in pain threshold (Fields et al., 1983 (Fields et al., , 1991 . Among those neurotransmitters is ACh. Cholinergic (AChE-or ChAT-positive) cells have been identified within the NRM in previous anatom-ical studies (Bowker et al., 1983; Jones et al., 1986; Sherriff et al., 1991) . The NRM receives cholinergic afferents originating from the cells in the pedunculopontine tegmental nucleus (Rye et al., 1988) . Behavioral studies have shown that local applications of both muscarinic receptor agonists and antagonists into the NRM cause antinociception (Brodie and Proudfit, 1986; Iwamoto, 1991) . In previous in vivo studies, iontophoretic application of ACh has been reported to induce an inhibition or excitation in the spontaneous activity of different groups of the NRM cells (Behbehani, 1982; Wessendorfand Anderson, 1983; Willcockson et al., 1983; Hentall et al., 1993) . Neither the cellular mechanism underlying the actions of these cholinergic agents on NRM neurons nor the muscarinic receptor subtypes that mediate the cholinergic actions is known.
The actions of ACh acting at muscarinic receptors in the CNS include a depolarization resulting from a reduction in a potassium conductance (Brown and Adams, 1980; Madison et al., 1987; Uchimura and North, 1990 ) and a hyperpolarization as a result of an increase in a potassium conductance (Egan and North, 1986; McCormick and Prince, 1987; McCormick and Pape, 1988; Gerber et al., 199 1) . Muscarinic cholinergic receptors consist of a heterogeneous family of five different subtypes (ml-m5) that have been cloned from rats (Kubo et al., 1986; Bonner et al., 1987 Bonner et al., , 1988 . The ml-m3 receptors correspond most closely to the pharmacologically defined M,-M, receptors (Kubo et al., 1986; Brann et al., 1988; Maeda et al., 1988; Buckley et al., 1989) . The ml, m3, and m5 receptors are functionally coupled primarily to the stimulation of inositol phosphate metabolism through a pertussis toxin-insensitive G-protein, while the m2 and m4 receptors are associated mainly with an inhibition of CAMP production through a pertussis toxinsensitive G-protein Fukuda et al., 1988; Peralta et al., 1988; Wess et al., 1990; Lai et al., 1991) . In rat brainstem, the presence of all five receptor subtypes or their mRNAs has been reported Ehlert and Trait, 1990; Levey et al., 199 1; Li et al., 199 1; Zubieta and Frey, 1993) .
In this study, we examined the direct actions of muscarine on the neurons in the NRM in a slice preparation and then identified the ionic mechanism and the receptor subtype involved in the muscarine-induced hyperpolarization observed in a subpopulation of neurons in the NRM.
Preliminary results of this study have been presented as an abstract (Pan and Williams, 199 1) .
Materials and Methods
Intracellular recordings were made from NRM cells in brain slices from adult Wistar rats. The methods employed were similar to those published previously (Pan et al., 1990) . Briefly, brain slices (300 pm thick)
2 min were cut in a vibratome in cold (4°C) physiological saline. Two or three coronal slices were taken from the level of the facial nerve in each brain. A single slice was submerged in a tissue bath through which flowed physiological saline (1.5 ml/min) at 37°C. The content of physiological saline solution was (in mM) NaCl, 126; KCl, 2.5; NaH,PO,, 1.2; MgCl,, 1.2; CaCl, 2.4; glucose, 11; NaHCO,, 25; gassed with 95% O,, 5% CO, at 37°C. The NRM was recognized in the slice as a triangular area in the midline just above the pyramidal tracts. Neurons were penetrated with glass microelectrodes filled with potassium chloride (2 M) having resistances of 40-70 MQ. Membrane currents were recorded with a singleelectrode voltage-clamp amplifier (Axoclamp 2A) using switching frequencies between 3 and 6 kHz. The settling time of the clamp following a 10 mV step was typically 3-5 msec. Steady state current-voltage (Iv) plots were constructed directly on an x,y-plotter using a slow depolarizing ramp potential. The speed of the ramp (1 mV/sec) was sufficiently slow to give the same current as that measured at the termination of a 2 set voltage step.
Drugs were applied by superfusion. The following drugs and salts were used: muscarine (Sigma), carbachol (Sigma), pirenzepine (PZP; Research Biochemical Inc.), methoctramine (Research Biochemicals Inc.), 5-hydroxytryptamine (5-HT; Sigma), 5-carboxamidotryptamine (5-CT; Glaxo), BaClz (Sigma), tetrodotoxin (TTX; Sigma). Dose-response data were fitted by logistic equation and the EC,, was then determined. Schild analysis was carried out by determining the dose ratios at the EC,, values in the absence and presence of the antagonist (Schild, 1949) . Numerical data are presented as means ? SE of the means and compared using an unpaired, two-tailed Student's t test.
Results
In a previous study, two groups of cells in the NRM have been described: primary and secondary (Pan et al., 1990) . Primary cells have action potential duration of > 1 msec and are 5-HT containing (>90%, Pan et al., 1993) ; opioids do not affect the resting membrane potential but inhibit the GABA synaptic potential in primary cells. Secondary cells have shorter action potential duration (< 1 msec) and are hyperpolarized by opioids. Muscarinic agonists were tested on a total of 148 cells: 73 cells were hyperpolarized, 2 1 cells were depolarized, and 54 cells were not affected. TTX (1 FM) did not change the muscarine-induced depolarization or hyperpolarization in all cells tested (n = 24).
Muscarine hyperpolarized a subgroup of primary cells Of the 148 cells, 98 were unequivocally identified (74 primary, 24 secondary). In the primary cell group, 41 cells were hyperpolarized by muscarine (55%; Fig. lA) , no depolarizations were observed, and the other 33 primary cells were not affected. The muscarine-induced hyperpolarization had a threshold at 1 PM Figure 1 . Hyperpolarization induced by muscarinic receptor agonists in neurons in the NRM. A, Membrane potential recordings of an NRM cell that was hyperpolarized by increasing concentrations of muscarine. B, Dose-response curves for the hyperpolarization induced by muscarine (EC,, = 2.7 PM, n = 8) and by carbachol (EC,, = 3.8 PM, n = 7). Data points are expressed as a percentage of the maximum hyperpolarization by 30 WM muscarine (9.8 + 1.1 mV) and by 30 PM carbachol(9.4 + I. 1 mV), respectively. Error bars are SE of the mean. and a maximum hyperpolarization of 9.8 +-1.1 mV (n = 8) at 30 FM. The EC,, was 2.7 FM (Fig. 1B) . Carbachol, a muscarinic receptor agonist, also hyperpolarized these cells in a dose-dependent manner over a similar concentration range (l-30 PM; Fig. lB) , inducing a maximum hyperpolarization of 9.4 + 1.1 mV (n = 7) at 30 FM and having an EC,, of 3.8 WM.
In 2 1 of 148 cells (14%), muscarine (10 FM) induced a depolarization of 4.8 * 0.6 mV (n = 21) which often resulted in the firing of repetitive action potentials. The muscarine-induced depolarization was observed almost exclusively in secondary cells.
Muscarine activated an inwardly rectifying potassium conductance In voltage clamp, muscarine produced an outward current at the resting membrane potential associated with an increase in membrane conductance (n = 24; Fig. 2A ). At more negative potentials than the resting potential, the muscarine-induced current declined in amplitude and reversed polarity. The averaged reversal potential of the muscarine-induced current was -103 * 2 mV (n = 17) in normal concentration of external potassium (2.5 mM). When the potassium concentration in the perfusing solution was increased to 6.5 mM and 10.5 mM, the reversal potential was shifted to -78 f 2 mV (n = 11) and -66 f 2 mV (n = 7) respectively (Fig. 2B) , giving a Nernst slope of -59.5 (Fig. 2C ). This suggested a primary involvement of a potassium conductance.
The muscarine-induced current exhibited inward rectification that was more obvious in higher concentrations of external potassium (Fig. 3A) . In 6.5 mM external potassium, the slope conductance of the muscarine-induced current measured between -50 and -60 mV was 1.0 t-0.2 nS and 5.2 + 1.0 nS between -100 and -110 mV (n = 10). Barium (30 FM) blocked the inwardly rectifying part ofthe muscarine current leaving a small, linear current (Fig. 3A) .
Muscarine and 5-HT hyperpolarized the cell by increasing the same inwardly rectifying potassium conductance Many cells in the NRM were hyperpolarized by 5-HT (10 or 30 PM). The currents induced by 5-HT in voltage clamp had the same inward rectification and barium sensitivity as that induced by muscarine. The slope conductance of the 5-HTinduced current was 1.2 -t 0.1 nS between -50 and -60 mV . Muscarine-induced hyperpolarization is mediated through an increase in an inwardly rectifying potassium conductance. A, Steady state current-voltage plots in the absence and presence of muscarine (10 PM). The reversal potential is -94 mV. B, The current-voltage plots of the muscarine-induced current in three different external potassium concentrations from the same cell as in A. The muscarine-induced currents were determined by manual subtraction of the current in control from that in muscarine at 5 mV intervals. C, Dependence ofthe reversal potential of the muscarine current on the external potassium concentrations. The dotted line is the fit to the data points (means of 7-17 experiments, slope = -59.5). The solid line was determined by the Nernst equation where the internal potassium concentration was fixed at 135 mh4. and 8.4 f 0.8 nS between -100 and -110 mV. BaCl, (30 FM) abolished the inward rectification of the current induced by the 5-HT, receptor agonist 5-CT (300 nM; Fig. 3B ). Then the effect of muscarine was tested in the cells that were hyperpolarized by 5-HT. Out of 102 cells that were hyperpolarized by 5-HT, 58 cells (57%) were hyperpolarized by muscarine (Fig. 4A) . The hyperpolarizations induced by muscarine and by 5-HT were not additive. The membrane potential of other 5-HT-responding cells was either not affected (n = 41, 40%) or depolarized (n = 3, 3%) by muscarine (10 or 30 FM).
In voltage clamp, muscarine (30 PM) caused no more current in cells that were already treated with 5-HT (30 KM) or 5-CT (300 nM; n = 4; Fig. 4B ). These results suggest that the same inwardly rectifying potassium conductance is involved in the muscarine-and 5-HT-induced hyperpolarization in these NRM cells.
Muscarine-induced hyperpolarization is mediated through an M, receptor subtype To identify the receptor subtype involved in the muscarine action, the concentration-response relationship for muscarine was constructed in the absence and presence of different concentrations of the muscarinic receptor antagonists PZP and methoctramine.
The control dose-response curve for muscarine (EC,, = 2.7 PM) was shifted to the right by increasing concentrations of PZP (Fig. 5A ). These shifts were parallel and the same maximum effect was maintained, indicating a competitive antagonism. The EC,, for muscarine was 6.0 PM, 15.4 PM, and 44.3 PM in 300 nM (n = 4) 1 PM (n = 4) and 3 PM PZP (n = 3) respectively. The Kd for PZP for the receptor subtype mediating the muscarine response was estimated using Schild analysis. Dose ratios were determined by EC,, values in different concentrations of PZP divided by the EC,, in control. We chose to use EC,, for the Schild analysis because the value was within the straight portion of parallel dose-response curves. The resulting Schild plot (Fig.  5B ) was linear and the best-fitted line through the data points had a slope of 1.05 that is not significantly different from unity. pK, was calculated for each concentration of PZP and the corresponding dose ratio (DR) according to the equation: pK,, = log(DR -l), -log[PZP],. The mean pK, calculated from each pK,, (n = 11) was 6.64 + 0.07 (95% confidence limits, 6.49-6.79) and the Kd for PZP was 230 nM (162-324 nM). Regression of calculated pKa estimates on the corresponding concentrations of PZP is shown in Figure 5C . No significant regression was obtained (t = 0.4, df = 9), indicating that the estimated pK, values (thus the Kd for PZP) were independent of the antagonist concentration. The dose-response curve for muscarine was also shifted to the right with the same maximum effect by increasing concentrations of methoctramine (Fig. 6A) . The EC,, for muscarine was 10.7 PM and 23.1 FM in 50 nM (n = 5) and 100 nM (n = 4) methoctramine, respectively. In 200 nM methoctramine (n = 3) the EC,, was 83.9 PM, 31-fold larger than that in control. The Schild plot shown in Figure 6B had a best-fitted line (xintercept = -7.56) with a slope of 1.67. This value was significantly different from unity, possibly indicating nonequilibrium steady states in drug-receptor interactions at the lower antagonist concentrations (see Discussion). The Kd value calculated from the dose ratio (3 1 -fold) at 200 nM methoctramine was then estimated to be 7 nM, according to the equation Kd = [antagonist]/(DR -1) (Kachur et al., 1990) .
Discussion
The muscarinic receptor subtype involved
The coupling of muscarinic receptor activation to a potassium conductance increase in the CNS was first reported by Egan and North (1986) in rat parabrachial neurons. Involvement of an M, (previous definition) subtype was suggested based on the lower affinity of the receptor for PZP (Kd = 600 nM) versus the higher-affinity PZP sites (M,) (Hammer et al., 1980) . Further development of muscarinic receptor antagonists has resulted in the current recognition of three pharmacologically defined sub- types with the M, further divided into M, (previously defined cardiac M,) and M, (previous glandular M,) (Bonner, 1989 ). In addition, five different muscarinic receptors have been cloned and radioligand binding studies have demonstrated that none of the antagonists has fivefold or higher affinity for one subtype over another (Buckley et al., 1989) . In the present study, PZP and methoctramine were used to determine the receptor subtype involved because of their higher ability to discriminate by affinity the M, and MZ subtypes, respectively, from other subtypes (Buckley et al., 1989) . Previously, in both radioligand binding studies (Akiba et al., 1988; Lai et al., 1988; Buckley et al., 1989; Lazareno and Roberts, 1989; Mei et al., 1989; Dorje et al., 1991) and functional studies (Lai et al., 1988; Lazareno and Roberts, 1989; McKinney et al., 1989a,b; Kachur et al., 1990; Sugita et al., 1991) (Buckley et al., 1989; Lazareno and Roberts, 1989; Wess et al., 1990; Dorje et al., 199 1) and functional studies (Melchiorre et al., 1987; Lazareno and Roberts, 1989; McKinneyet al., 1989b; Kachuretal., 1990; Sugitaetal., 1991) . Among the selective M, antagonists, methoctramine is comparatively the best in discriminating M, from the other three subtypes with the M, subtype excluded (Bonner, 1989) . In the present study, no reliable K,, value for methoctramine could be obtained as the slope of the Schild plot was significantly greater than unity. This most likely resulted from nonequilibrium steady states in the drug-receptor interactions at the lower antagonist concentrations, due to an inadequate period of time (20 min in this study) for equilibrium to be achieved. This would result in an underestimate of the dose ratio at the lower antagonist concentrations and a steeper Schild regression slope. If this is the case, the equilibrium conditions could be obtained by increasing the interaction time at lower concentrations of the antagonist (practically difficult in this study). The Kd estimate with a slope of unity would then be smaller than the value indicated by the x-intercept of a fitted line with the slope greater than unity (Kenakin, 1987) . In our case, the actual PK,~ value was probably less than -7.56 as indicated by the x-intercept of best-fitted line through the data points (thus Kd < 28 nM). As an estimate, the Kd calculated from the dose ratio (3 1 -fold) at 200 nM methoctramine was 7 nM. Therefore, the Kd for methoctramine appears to be < 30 nM, which is consistent with the previously described methoctramine Kd range for the M, subtype. Taken together, it seems reasonable to conclude that the muscarinic receptor mediating the hyperpolarization in these NRM cells is of the M, subtype. This is in agreement with previous anatomical 'studies, where a relatively high density of M, and low density of M, and M, receptors Ehlert and Tran, 1990; Levey et al., 199 1; Li et al., 199 1; Zubieta and Frey, 1993) were found in rat brainstem structures including the NRM (Quirion et al., 1989) . Only low levels of m4 and m5 receptor proteins were detected in the rat brainstem area (Levey et al., 199 1; Yasuda et al., 1993) .
The inwardly rectifying potassium conductance We have shown that the muscarine-induced hyperpolarization in these NRM neurons was mediated through an increase in a barium-sensitive, inwardly rectifying potassium conductance. The muscarinic receptor activation of the potassium conductance originally reported in the CNS parabrachial neurons (Egan and North, 1986) was linearly dependent on the membrane potential. Recently, Gerber et al. (1991) characterized an inwardly rectifying potassium conductance activated by muscarinic agonists in rat pontine reticular formation neurons and the involvement of a non-M, subtype was suggested. The potassium conductance in that study was similar in both the membrane potential dependence (inward rectification) and barium sensitivity to that described here. We have also shown that both muscarine and 5-HT hyperpolarized a subgroup of NRM cells through an increase in a similar inwardly rectifying potassium conductance. The reversal potentials of both 5-HT and muscarinic currents were at the predicted potassium equilibrium potential, indicating that voltage control was sufficient for each and suggesting that the currents arose from areas of the cell that were electrotonically similar. In addition, the currents induced by muscarine and by 5-CT were not additive. We and others have used this approach to suggest that different agonists acting on separate receptors activate a common inwardly rectifying potassium conductance (North and Williams, 1985; Andrade et al., 1986; Christie and North, 1988) .
Functional considerations
The results reported here are consistent with previous in vivo studies where iontophoretic application of ACh into the NRM inhibited the spontaneous activity in the majority of the cells (Wessendorf and Anderson, 1983; Hentall et al., 1993) . In addition, a more consistent inhibition was found specifically in raphe-spinal serotonergic cells (Wessendorf and Anderson, 1983) . Other studies, however, have reported excitation of most cells in the NRM in response to iontophoretic ACh (Behbehani, 1982; Willcockson et al., 1983) . This discrepancy may largely be attributed to the use of ACh that can act on both muscarinic and nicotinic receptors. Both receptor types are thought to be involved in modulation of the cellular activity and of antinociceptive function of the NRM (Iwamoto, 199 1) .
Generally, the activation of the cells, particularly the raphe-spinal projection cells, in the NRM produces antinociception bachol into the NRM also induced antinociception. However, through descending inhibition (Basbaum and Fields, 1984) . A recent behavioral study has shown that local injection of meththis effect did not annear to be mediated bv serotoneraic neurons octramine into the NRM produced a strong antinociceptive response in rats (Iwamoto, 199 1) . This implies the possibility of a tonic inhibitory muscarinic modulation of the NRM neurons responsible for the descending inhibition. In an earlier report, local application of the muscarinic receptor agonist car- . . in the NRM (Brodie and Proudfit, 1986 ). The present results implicate an inhibitory cholinergic postsynaptic modulation on some of the serotonergic neurons in the NRM. These same neurons could presumably be activated by opioids through GABA-mediated disinhibition and may contribute to the descending modulation of sensory inputs (Pan et al., 1990) .
